Brett Granger

Person

Sudbury, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridines as apoptosis signal-regulating kinase 1 inhib...
- Patent number 11,466,033
- Issue date Oct 11, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,420,976
- Issue date Aug 23, 2022
- Enanta Pharmaceuticals, Inc.
- Yong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,345,699
- Issue date May 31, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,040,998
- Issue date Jun 22, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,008,304
- Issue date May 18, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,988,458
- Issue date Apr 27, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibito...
- Patent number 10,968,199
- Issue date Apr 6, 2021
- Enanta Pharmaceuticals, Inc.
- Jing He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonyl carbamate bile acid derivatives
- Patent number 10,961,272
- Issue date Mar 30, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,289
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,279
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonyl carbamate bile acid derivatives
- Patent number 10,676,500
- Issue date Jun 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 10,597,382
- Issue date Mar 24, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR agonists and methods of use thereof
- Patent number 10,472,386
- Issue date Nov 12, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,457,703
- Issue date Oct 29, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,450,301
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,253,018
- Issue date Apr 9, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,246,439
- Issue date Apr 2, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,149,835
- Issue date Dec 11, 2018
- Elmore Patent Law Group, P.C.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,144,729
- Issue date Dec 4, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use therof
- Patent number 10,138,228
- Issue date Nov 27, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,741
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,743
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,742
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...
- Publication number 20230143250
- Publication date May 11, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220402966
- Publication date Dec 22, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20220356167
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20220119366
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS
- Publication number 20210238188
- Publication date Aug 5, 2021
- Enanta Pharmaceuticals, Inc.
- Yong He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200331890
- Publication date Oct 22, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYL CARBAMATE BILE ACID DERIVATIVES
- Publication number 20200317717
- Publication date Oct 8, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200308193
- Publication date Oct 1, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200157095
- Publication date May 21, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200109164
- Publication date Apr 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOALKYL-CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITO...
- Publication number 20200062727
- Publication date Feb 27, 2020
- Enanta Pharmaceuticals, Inc.
- Jing He
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20190337935
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190337923
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190062310
- Publication date Feb 28, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20180362501
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362502
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362503
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180327388
- Publication date Nov 15, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for Preparation of Sulfonyl Carbamate Bile Acid Derivatives
- Publication number 20180291058
- Publication date Oct 11, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20180237471
- Publication date Aug 23, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
- Publication number 20170334894
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
- Publication number 20170333399
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoxazole Analogs as FXR Agonists and Methods of Use Thereof
- Publication number 20170334893
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20170304270
- Publication date Oct 26, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20170304271
- Publication date Oct 26, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Brett Granger

Person

Patents Grantslast 30 patents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Substituted pyridines as apoptosis signal-regulating kinase 1 inhib...

Heterocyclic compounds as anti-viral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibito...

Process for preparation of sulfonyl carbamate bile acid derivatives

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Process for preparation of sulfonyl carbamate bile acid derivatives

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Bile acid derivatives as FXR agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use therof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

PROCESS FOR PREPARATION OF SULFONYL CARBAMATE BILE ACID DERIVATIVES

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

CYCLOALKYL-CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITO...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

Process for Preparation of Sulfonyl Carbamate Bile Acid Derivatives

BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof

Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof

Isoxazole Analogs as FXR Agonists and Methods of Use Thereof

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF